Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Charles

Showing results (361-370 of 519) with videos related to

Pageof 52
Sort By:
Molecular Cancer Research : MCR|January 14, 2010
FOXM1 confers acquired cisplatin resistance in breast cancer cellsJimmy M-M Kwok, Barrie Peck, Lara J Monteiro, et al.
Molecular Cancer Research : MCR|March 3, 2026
Expression of Concern: FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer CellsJimmy M-M Kwok, Barrie Peck, Lara J Monteiro, et al.
Oncogene|September 19, 2019
ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942Georgina P Sava, Hailing Fan, Rosemary A Fisher, et al.
Journal of Cancer Research and Clinical Oncology|July 20, 2007
A phase II trial of docetaxel (Taxotere) as second-line chemotherapy in patients with metastatic breast cancerMartina Baur, Allan T van Oosterom, Véronique Diéras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell linesJohn Patrick Alao, Eric W-F Lam, Simak Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
The expression of ER beta cx in human breast cancer and the relationship to endocrine therapy and survivalCarlo Palmieri, Eric W-F Lam, Janine Mansi, et al.
European Journal of Biochemistry|March 1, 1995
Isolation and characterization of the rat gene for carbamoylphosphate synthetase IM J van den Hoff, L P van de Zande, M A Dingemanse, et al.
Clinical Lung Cancer|January 24, 2012
Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early resultsBradford S Hoppe, Stella Flampouri, Randal H Henderson, et al.
Future Oncology (London, England)|June 1, 2014
The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancyJustin Stebbing, Victoria Harding, Catherine E Urch, et al.
Chemmedchem|September 11, 2012
Discovery of a new class of liver receptor homolog-1 (LRH-1) antagonists: virtual screening, synthesis and biological evaluationJullien Rey, Haipeng Hu, Fiona Kyle, et al.
Pageof 52

Showing results (361-370 of 519) with videos related to

Sort By:
Pageof 52
Molecular Cancer Research : MCR|January 14, 2010
FOXM1 confers acquired cisplatin resistance in breast cancer cellsJimmy M-M Kwok, Barrie Peck, Lara J Monteiro, et al.
Molecular Cancer Research : MCR|March 3, 2026
Expression of Concern: FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer CellsJimmy M-M Kwok, Barrie Peck, Lara J Monteiro, et al.
Oncogene|September 19, 2019
ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942Georgina P Sava, Hailing Fan, Rosemary A Fisher, et al.
Journal of Cancer Research and Clinical Oncology|July 20, 2007
A phase II trial of docetaxel (Taxotere) as second-line chemotherapy in patients with metastatic breast cancerMartina Baur, Allan T van Oosterom, Véronique Diéras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell linesJohn Patrick Alao, Eric W-F Lam, Simak Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
The expression of ER beta cx in human breast cancer and the relationship to endocrine therapy and survivalCarlo Palmieri, Eric W-F Lam, Janine Mansi, et al.
European Journal of Biochemistry|March 1, 1995
Isolation and characterization of the rat gene for carbamoylphosphate synthetase IM J van den Hoff, L P van de Zande, M A Dingemanse, et al.
Clinical Lung Cancer|January 24, 2012
Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early resultsBradford S Hoppe, Stella Flampouri, Randal H Henderson, et al.
Future Oncology (London, England)|June 1, 2014
The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancyJustin Stebbing, Victoria Harding, Catherine E Urch, et al.
Chemmedchem|September 11, 2012
Discovery of a new class of liver receptor homolog-1 (LRH-1) antagonists: virtual screening, synthesis and biological evaluationJullien Rey, Haipeng Hu, Fiona Kyle, et al.
Pageof 52